TREATGermany registry: "real-world effectiveness" of dupilumab in atopic dermatitis

被引：1
|
作者：
Weidinger, S. [1 ]
Stoelzl, D. [1 ]
Abraham, S. [2 ]
Haufe, E. [3 ,4 ]
Heratizadeh, A. [5 ]
Werfel, T. [5 ]
Schmitt, J. [3 ,4 ]
机构：
[1] Univ Hosp Schleswig Holstein, Dept Dermatol & Allergy, Ctr Inflammatory Skin Dis, Campus Kiel, Kiel, Germany
[2] TU Dresden, Med Fac Carl Gustav Carus, Univ Allergy Ctr, Dept Dermatol, Dresden, Germany
[3] TU Dresden, Ctr Evidence Based Healthcare, Univ Hosp, Dresden, Germany
[4] TU Dresden, Med Fac Carl Gustav Carus, Dresden, Germany
[5] Hannover Med Sch, Dept Dermatol & Allergy, Div Immunodermatol & Allergy Res, Hannover, Germany
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 09期
关键词：
D O I：
10.1016/j.jid.2019.07.131
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
127
引用
收藏
页码：S236 / S236
页数：1
相关论文
共 50 条
  • [1] Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry
    Stoelzl, Dora
    Sander, Nicole
    Heratizadeh, Annice
    Haufe, Eva
    Harder, Inken
    Abraham, Susanne
    Heinrich, Luise
    Kleinheinz, Andreas
    Wollenberg, Andreas
    Weisshaar, Elke
    Schaekel, Knut
    Ertner, Konstantin
    Wiemers, Franca
    Wildberger, Julia
    Worm, Margitta
    von Kiedrowski, Ralph
    Effendy, Isaak
    Asmussen, Andrea
    Augustin, Matthias
    Pawlak, Mario
    Sticherling, Michael
    Zink, Alexander
    Hilgers, Melanie
    Handrick, Christiane
    Quist, Sven
    Schwarz, Beate
    Staubach-Renz, Petra
    Bell, Magnus
    Hong-Weldemann, Sun-Hei
    Homey, Bernhard
    Bruecher, Jens-Joachim
    Schmitt, Jochen
    Werfel, Thomas
    Weidinger, Stephan
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (06) : 1022 - 1024
  • [2] Real-world effectiveness of dupilumab for the treatment of atopic dermatitis in adult and pediatric patients
    Emmerich, Veronica K.
    Williams, Josiah
    Hrin, Matthew L.
    Newsom, Megan
    Feldman, Steven R.
    Strowd, Lindsay C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB199 - AB199
  • [3] Real-world experience of dupilumab treatment for atopic dermatitis
    Martinez Mariscal, Jaime
    Cabana-Navia, Raquel
    Martinez-Fernandez, Alicia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
  • [4] Predictive features for effectiveness of dupilumab in elderly patients with atopic dermatitis: a real-world study
    Jia, Qiqi
    Cao, Qiaozhi
    Peng, Cong
    Shui, Xinyu
    Li, Jie
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024,
  • [5] Real-World data on efficacy, safety and persistence of dupilumab: An analysis from the TREATgermany registry
    Sander, Nicole
    Stoelzl, Dora
    Heratizadeh, Annice
    Haufe, Eva
    Harder, Inken
    Schmitt, Jochen
    Werfel, Thomas
    Weidinger, Stephan
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 72 - 73
  • [6] Real-World data on efficacy, safety and persistence of dupilumab: An analysis from the TREATgermany registry
    Sander, N.
    Stoelzl, D.
    Heratizdaeh, A.
    Haufe, E.
    Harder, I.
    Schmitt, J.
    Werfel, T.
    Weidinger, S.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S196 - S196
  • [7] Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry
    Kojanova, Martina
    Tanczosova, Milena
    Strosova, Daniela
    Cetkovska, Petra
    Fialova, Jorga
    Dolezal, Tomas
    Machovcova, Alena
    Gkalpakiotis, Spyridon
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2578 - 2586
  • [8] Real-world persistence with dupilumab among adults with atopic dermatitis
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Gadkari, Abhijit
    Kuznik, Andreas
    Mallya, Usha G.
    Mastey, Vera
    Zhang, Haixin
    Chen, Zhen
    Chen, Cheng
    Korotzer, Andrew
    Sierka, Debra
    Fenton, Miriam C.
    Kaur, Mandeep
    Jalbert, Jessica J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (01) : 40 - 45
  • [9] Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry
    Stoelzl, D.
    Boraczynski, N.
    Heratizadeh, A.
    Haufe, E.
    Harder, I.
    Abraham, S.
    Heinrich, L.
    Kleinheinz, A.
    Wollenberg, A.
    Weisshaar, E.
    Schaekel, K.
    Ertner, K.
    Wiemers, F.
    Wildberger, J.
    Worm, M.
    von Kiedrowski, R.
    Effendy, I.
    Asmussen, A.
    Augustin, M.
    Pawlak, M.
    Sticherling, M.
    Zink, A.
    Hilgers, M.
    Handrick, C.
    Quist, S.
    Schwarz, B.
    Staubach-Renz, P.
    Bell, M.
    Hong-Weldemann, S.
    Homey, B.
    Bruecher, J.
    Schmitt, J.
    Werfel, T.
    Weidinger, S.
    [J]. EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : E39 - E40
  • [10] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients With Atopic Dermatitis: 2-Year Data From the PROSE Registry
    Simpson, Eric L.
    Lockshin, Benjamin
    Lee, Lara Wine
    Chen, Zhen
    Daoud, Moataz
    Korotzer, Andrew
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB81 - AB81
12345